drugset / Trial / NCT00650611
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of oral ziprasidone in children and teens with psychotic disorders
Timeline
- Start
- 2003-12
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ziprasidone | Small molecule | 40 mg | Oral |
| Comparator | Ziprasidone | Small molecule | 80 mg | Oral |